Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Infect Dis ; 47(9): 1188-96, 2008 Nov 01.
Article in English | MEDLINE | ID: mdl-18808353

ABSTRACT

BACKGROUND: Rickettsia parkeri rickettsiosis, a recently identified spotted fever transmitted by the Gulf Coast tick (Amblyomma maculatum), was first described in 2004. We summarize the clinical and epidemiological features of 12 patients in the United States with confirmed or probable disease attributable to R. parkeri and comment on distinctions between R. parkeri rickettsiosis and other United States rickettsioses. METHODS: Clinical specimens from patients in the United States who reside within the range of A. maculatum for whom an eschar or vesicular rash was described were evaluated by > or =1 laboratory assays at the Centers for Disease Control and Prevention (Atlanta, GA) to identify probable or confirmed infection with R. parkeri. RESULTS: During 1998-2007, clinical samples from 12 patients with illnesses epidemiologically and clinically compatible with R. parkeri rickettsiosis were submitted for diagnostic evaluation. Using indirect immunofluorescence antibody assays, immunohistochemistry, polymerase chain reaction assays, and cell culture isolation, we identified 6 confirmed and 6 probable cases of infection with R. parkeri. The aggregate clinical characteristics of these patients revealed a disease similar to but less severe than classically described Rocky Mountain spotted fever. CONCLUSIONS: Closer attention to the distinct clinical features of the various spotted fever syndromes that exist in the United States and other countries of the Western hemisphere, coupled with more frequent use of specific confirmatory assays, may unveil several unique diseases that have been identified collectively as Rocky Mountain spotted fever during the past century. Accurate assessments of these distinct infections will ultimately provide a more valid description of the currently recognized distribution, incidence, and case-fatality rate of Rocky Mountain spotted fever.


Subject(s)
Rickettsia Infections/diagnosis , Rocky Mountain Spotted Fever/diagnosis , Adult , Aged , Animals , Antibodies, Bacterial/blood , Arachnid Vectors/microbiology , DNA, Bacterial/genetics , Diagnosis, Differential , Female , Humans , Ixodidae/microbiology , Male , Middle Aged , Rickettsia/genetics , Rickettsia/immunology , Rickettsia/isolation & purification , Rickettsia/pathogenicity , Rickettsia Infections/microbiology , Rickettsia Infections/transmission , United States
2.
Clin Infect Dis ; 38(6): 805-11, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-14999622

ABSTRACT

Ticks, including many that bite humans, are hosts to several obligate intracellular bacteria in the spotted fever group (SFG) of the genus Rickettsia. Only Rickettsia rickettsii, the agent of Rocky Mountain spotted fever, has been definitively associated with disease in humans in the United States. Herein we describe disease in a human caused by Rickettsia parkeri, an SFG rickettsia first identified >60 years ago in Gulf Coast ticks (Amblyomma maculatum) collected from the southern United States. Confirmation of the infection was accomplished using serological testing, immunohistochemical staining, cell culture isolation, and molecular methods. Application of specific laboratory assays to clinical specimens obtained from patients with febrile, eschar-associated illnesses following a tick bite may identify additional cases of R. parkeri rickettsiosis and possibly other novel SFG rickettsioses in the United States.


Subject(s)
Rickettsia Infections/microbiology , Rickettsia/isolation & purification , Rocky Mountain Spotted Fever/microbiology , Tick-Borne Diseases/microbiology , Adult , Animals , Humans , Male , Rocky Mountain Spotted Fever/epidemiology , Tick-Borne Diseases/epidemiology , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...